Proposition of Splenic Dose-Volume Constraints to Prevent Severe Lymphopenia after Chemoradiation for Pancreatic Cancer
نویسندگان
چکیده
منابع مشابه
Efficacy of Intraoperative, Single-Bolus Corticosteroid Dose to Prevent Postoperative Respiratory Complication after Transhiatal Esophagectomy
Introduction: Esophageal cancer is among the most common malignancies. Hospital mortality in the past decade reduced; but its morbidity is still high. Pulmonary complications are the most common complications after esophageal resection. In this study we examined the effect of steroids administration during surgery to reduce postoperative morbidity with a focus on respiratory complications.Mater...
متن کاملSplenic infarction in pancreatic cancer.
A 70-year-old man with a 17-year history of ischemic heart disease presented with epigastric pain, body weight loss and fatigue of a two-month duration. On examination, there was no tenderness on palpation of the abdomen. Laboratory tests of tumor markers revealed a CA 19-9 of 37 U/mL (reference range: 0-37 U/mL), a DUPAN-2 of 1,200 U/mL (reference range: 0-150 U/mL) and a SPan-1 of 7,300 U/mL ...
متن کاملUniformity of Dose Distribution in Target Volume in Radiotherapy Techniques for Breast after Mastectomy.
Background & Objective: Radiotherapy has a very special significance in the treatment of cancer. Beam radiation therapy using photons and electrons produced by a linear accelerator is used extensively in the treatment of breast Cancer. In this article, In addition to providing a description of three techniques of radiotherapy in the treatment of breast cancer, has been Evaluating the effectiven...
متن کاملPreoperative chemoradiation in resectable pancreatic cancer.
Despite advancements in the field of surgical oncology, the diagnosis of pancreatic cancer still carries a grave and dismal prognosis. Surgery alone for adenocarcinoma of the pancreatic head or uncinate process has a median survival time of 12 months. These grim statistics have led many to study the effects of combined multimodality therapy in the fight against pancreatic cancer. The long recov...
متن کاملInterferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
BACKGROUND Patients with cancer who undergo pancreaticoduodenectomy (PD) followed by radiation and 5-fluorouracil (5-FU) therapy have experienced median overall survival from 18 to 24 months and an actuarial 2-year overall survival from 34% to 48%. We previously reported an 84% 2-year survival using a novel adjuvant chemoradiation protocol that included alpha interferon. This report describes t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Radiation Oncology*Biology*Physics
سال: 2018
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2018.07.410